Management of Pemphigus in COVID-19 Pandemic Era; a Review Article
Introduction: The novel coronavirus is rapidly spreading around the world. Since the public announcement of the COVID-19 outbreak, several concerns have been raised by dermatologists as well as pemphigus patients who take immunosuppressive drugs. In this paper, we review the literature about the com...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Shahid Beheshti University of Medical Sciences
2020-04-01
|
| Series: | Archives of Academic Emergency Medicine |
| Subjects: | |
| Online Access: | https://journals.sbmu.ac.ir/aaem/index.php/AAEM/article/view/663 |
| _version_ | 1831560659574194176 |
|---|---|
| author | Fahimeh Abdollahimajd Mohammad Shahidi-Dadras Reza M Robati Sahar Dadkhahfar |
| author_facet | Fahimeh Abdollahimajd Mohammad Shahidi-Dadras Reza M Robati Sahar Dadkhahfar |
| author_sort | Fahimeh Abdollahimajd |
| collection | DOAJ |
| description | Introduction: The novel coronavirus is rapidly spreading around the world. Since the public announcement of the COVID-19 outbreak, several concerns have been raised by dermatologists as well as pemphigus patients who take immunosuppressive drugs. In this paper, we review the literature about the common treatment of pemphigus with a focus on the lessons from similar epidemics to find a proper suggestion to manage pemphigus in the COVID-19 pandemic era. The effect of many of the drugs used for treatment of Pemphigus vulgaris (PV) on COVID-19 is not clear. We also do not have data on the impact of this autoimmune disease, which may involve the mucous membranes, on the acquisition or course of COVID-19. We are currently in the midst of a pandemic and evaluating the effect of COVID-19 on the population of susceptible patients suffering from auto-immune diseases like pemphigus is essential. The evidence on best ways to manage patients with underlying conditions, such as pemphigus, during the outbreak of COVID-19 is evolving and the data is updated every day. |
| first_indexed | 2024-12-17T05:50:08Z |
| format | Article |
| id | doaj.art-a679f70bdc394553931ddb34ea1c845c |
| institution | Directory Open Access Journal |
| issn | 2645-4904 |
| language | English |
| last_indexed | 2024-12-17T05:50:08Z |
| publishDate | 2020-04-01 |
| publisher | Shahid Beheshti University of Medical Sciences |
| record_format | Article |
| series | Archives of Academic Emergency Medicine |
| spelling | doaj.art-a679f70bdc394553931ddb34ea1c845c2022-12-21T22:01:11ZengShahid Beheshti University of Medical SciencesArchives of Academic Emergency Medicine2645-49042020-04-018110.22037/aaem.v8i1.663414Management of Pemphigus in COVID-19 Pandemic Era; a Review ArticleFahimeh Abdollahimajd0Mohammad Shahidi-Dadras1Reza M Robati2Sahar Dadkhahfar31. Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.1. Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.1. Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 2. Department of Dermatology, Loghman Hakim Hospital, Shahid Beheshti of Medical Sciences.1. Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.Introduction: The novel coronavirus is rapidly spreading around the world. Since the public announcement of the COVID-19 outbreak, several concerns have been raised by dermatologists as well as pemphigus patients who take immunosuppressive drugs. In this paper, we review the literature about the common treatment of pemphigus with a focus on the lessons from similar epidemics to find a proper suggestion to manage pemphigus in the COVID-19 pandemic era. The effect of many of the drugs used for treatment of Pemphigus vulgaris (PV) on COVID-19 is not clear. We also do not have data on the impact of this autoimmune disease, which may involve the mucous membranes, on the acquisition or course of COVID-19. We are currently in the midst of a pandemic and evaluating the effect of COVID-19 on the population of susceptible patients suffering from auto-immune diseases like pemphigus is essential. The evidence on best ways to manage patients with underlying conditions, such as pemphigus, during the outbreak of COVID-19 is evolving and the data is updated every day.https://journals.sbmu.ac.ir/aaem/index.php/AAEM/article/view/663COVID-19pemphigussevere acute respiratory syndrome coronavirus 2therapy |
| spellingShingle | Fahimeh Abdollahimajd Mohammad Shahidi-Dadras Reza M Robati Sahar Dadkhahfar Management of Pemphigus in COVID-19 Pandemic Era; a Review Article Archives of Academic Emergency Medicine COVID-19 pemphigus severe acute respiratory syndrome coronavirus 2 therapy |
| title | Management of Pemphigus in COVID-19 Pandemic Era; a Review Article |
| title_full | Management of Pemphigus in COVID-19 Pandemic Era; a Review Article |
| title_fullStr | Management of Pemphigus in COVID-19 Pandemic Era; a Review Article |
| title_full_unstemmed | Management of Pemphigus in COVID-19 Pandemic Era; a Review Article |
| title_short | Management of Pemphigus in COVID-19 Pandemic Era; a Review Article |
| title_sort | management of pemphigus in covid 19 pandemic era a review article |
| topic | COVID-19 pemphigus severe acute respiratory syndrome coronavirus 2 therapy |
| url | https://journals.sbmu.ac.ir/aaem/index.php/AAEM/article/view/663 |
| work_keys_str_mv | AT fahimehabdollahimajd managementofpemphigusincovid19pandemiceraareviewarticle AT mohammadshahididadras managementofpemphigusincovid19pandemiceraareviewarticle AT rezamrobati managementofpemphigusincovid19pandemiceraareviewarticle AT sahardadkhahfar managementofpemphigusincovid19pandemiceraareviewarticle |